1887

Abstract

Purpose. Shiga toxin-producing Escherichia coli (STEC) represents a major issue for public health because of the severity of the associated illnesses, including haemolytic uraemic syndrome (HUS). In 2015, investigation of a case of HUS revealed an outbreak of Shiga toxin-2-producing E. coli O26 : H11 infection in a nursery in Italy. The investigation showed that the infection was transmitted to cases’ contacts via person to person.

Methods. The case finding was performed by testing for STEC stool samples of the HUS case's contacts within the family and the nursery. STEC O26 isolates were characterized by whole genome sequencing. Confirmed cases were repeatedly tested to monitor the duration of STEC shedding.

Results. Eleven STEC O26 cases were identified, including adults and asymptomatic patients. Clinical illness was only observed in children. Strain characterization revealed that a single clone harbouring the stx2a and eae genes and the complete array of STEC-associated virulence genes, belonging to ST(21), was implicated in the outbreak. To reduce bacterial shedding, patients were treated with cefixime following clinical recovery. This antibiotic was well tolerated and did not induce any apparent consequences on patients’ health.

Conclusions. This study confirms that Stx2-producing E. coli O26 represents an emerging public health problem. The occurrence of outbreaks of infection by Stx2-producing E. coli O26 in nurseries is of particular concern, given the high probability of infection progressing in severity and resulting in secondary cases.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000738
2018-04-23
2019-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/67/6/775.html?itemId=/content/journal/jmm/10.1099/jmm.0.000738&mimeType=html&fmt=ahah

References

  1. Karpman D, Loos S, Tati R, Arvidsson I. Haemolytic uraemic syndrome. J Intern Med 2017;281:123–148 [CrossRef][PubMed]
    [Google Scholar]
  2. Grisaru S, Xie J, Samuel S, Hartling L, Tarr PI et al. Associations between hydration status, intravenous fluid administration, and outcomes of patients infected with Shiga toxin-producing Escherichia coli: a systematic review and meta-analysis. JAMA Pediatr 2017;171:68–76 [CrossRef][PubMed]
    [Google Scholar]
  3. Mody RK, Griffin PM. Editorial commentary: increasing evidence that certain antibiotics should be avoided for Shiga toxin-producing Escherichia coli infections: more data needed. Clin Infect Dis 2016;62:1259–1261 [CrossRef][PubMed]
    [Google Scholar]
  4. Germinario C, Caprioli A, Giordano M, Chironna M, Gallone MS et al. Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing Escherichia coli O26:H11 in southern Italy, summer 2013. Euro Surveill 2016;21:30343 [CrossRef]
    [Google Scholar]
  5. Caprioli A, Morabito S, Scavia G. Public health microbiology of Shiga toxin-producing Escherichia coli. In Sperandio V, Hovde CJ. (editors) Enterohemorrhagic Escherichia coli and other shiga toxin-producing E. coli Washington, DC: ASM Press; 2014; pp.245–259 [CrossRef]
    [Google Scholar]
  6. Luzzi I, García-Fernández A, Dionisi AM, Lucarelli C, Gattuso A et al. 2017; Enter-Net Italia e Registro italiano della sindrome emolitico uremica: sorveglianza delle infezioni da Salmonella, Campylobacter, Escherichia coli produttore di Shiga-tossina e Listeria monocytogenes (2010-2015). Available athttp://old.iss.it/binary/publ/cont/17_34_web.pdf [accessed 05 March 2018]
  7. Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS et al. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol 2014;52:1501–1510 [CrossRef][PubMed]
    [Google Scholar]
  8. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012;9:357–359 [CrossRef][PubMed]
    [Google Scholar]
  9. Inouye M, Dashnow H, Raven LA, Schultz MB, Pope BJ et al. SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Med 2014;6:90 [CrossRef][PubMed]
    [Google Scholar]
  10. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012;19:455–477 [CrossRef][PubMed]
    [Google Scholar]
  11. Tritt A, Eisen JA, Facciotti MT, Darling AE. An integrated pipeline for de novo assembly of microbial genomes. PLoS One 2012;7:e42304 [CrossRef][PubMed]
    [Google Scholar]
  12. Joensen KG, Tetzschner AM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J Clin Microbiol 2015;53:2410–2426 [CrossRef][PubMed]
    [Google Scholar]
  13. Gardner SN, Slezak T, Hall BG. kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome. Bioinformatics 2015;31:2877–2878 [CrossRef][PubMed]
    [Google Scholar]
  14. Usein CR, Ciontea AS, Militaru CM, Condei M, Dinu S et al. Molecular characterisation of human Shiga toxin-producing Escherichia coli O26 strains: results of an outbreak investigation, Romania, February to August 2016. Euro Surveill 2017;22: [CrossRef][PubMed]
    [Google Scholar]
  15. Michelacci V, Orsini M, Knijn A, Delannoy S, Fach P et al. Development of a high resolution virulence allelic profiling (HReVAP) approach based on the accessory genome of Escherichia coli to characterize Shiga-toxin producing E. coli (STEC). Front Microbiol 2016;7:202 [CrossRef][PubMed]
    [Google Scholar]
  16. Kanayama A, Yahata Y, Arima Y, Takahashi T, Saitoh T et al. Enterohemorrhagic Escherichia coli outbreaks related to childcare facilities in Japan, 2010–2013. BMC Infect Dis 2015;15:539 [CrossRef][PubMed]
    [Google Scholar]
  17. Dallman TJ, Byrne L, Launders N, Glen K, Grant KA et al. The utility and public health implications of PCR and whole genome sequencing for the detection and investigation of an outbreak of Shiga toxin-producing Escherichia coli serogroup O26:H11. Epidemiol Infect 2015;143:1672–1680 [CrossRef][PubMed]
    [Google Scholar]
  18. Terajima JIS, Ohnishi M, Watanabe H. Shiga toxin (vedrotoxin)-producing Escherichia coli in Japan. In Sperandio V, Hovde CJ. (editors) Enterohemorrhagic Escherichia coli and Other Shiga Toxin-Producing E. coli Washington, DC: ASM Press; 2014; pp.199–209
    [Google Scholar]
  19. Moran-Gilad J, Rokney A, Danino D, Ferdous M, Alsana F et al. Real-time genomic investigation underlying the public health response to a Shiga toxin-producing Escherichia coli O26:H11 outbreak in a nursery. Epidemiol Infect 2017;145:2998–3006 [CrossRef][PubMed]
    [Google Scholar]
  20. Bielaszewska M, Mellmann A, Bletz S, Zhang W, Köck R et al. Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin Infect Dis 2013;56:1373–1381 [CrossRef][PubMed]
    [Google Scholar]
  21. European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC) The European Union summary report on trends and sources of zoonoses, zoonotic agents and foodborne outbreaks, 2016. EFSA J 2017;12:228
    [Google Scholar]
  22. Tokuda K, Yahata Y, Sunagawa T. Prevention of secondary household transmission during Shiga toxin-producing Escherichia coli outbreaks. Epidemiol Infect 2016;144:2931–2939 [CrossRef][PubMed]
    [Google Scholar]
  23. Garvey P, Carroll A, McNamara E, McKeown PJ. Verotoxigenic Escherichia coli transmission in Ireland: a review of notified outbreaks, 2004–2012. Epidemiol Infect 2016;144:917–926 [CrossRef][PubMed]
    [Google Scholar]
  24. Messens W, Bolton D, Frankel G, Liebana E, McLauchlin J et al. Defining pathogenic verocytotoxin-producing Escherichia coli (VTEC) from cases of human infection in the European Union, 2007–2010. Epidemiol Infect 2015;143:1652–1661 [CrossRef][PubMed]
    [Google Scholar]
  25. Bugarel M, Martin A, Fach P, Beutin L. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol 2011;11:142 [CrossRef][PubMed]
    [Google Scholar]
  26. Altmann M, Spode A, Altmann D, Wadl M, Benzler J et al. Timeliness of surveillance during outbreak of Shiga Toxin-producing Escherichia coli infection, Germany, 2011. Emerg Infect Dis 2011;17:1906–1909 [CrossRef][PubMed]
    [Google Scholar]
  27. Gallagher L, Soyemi K, Conover C, Austin C, Saathoff-Huber L et al. Outbreak of Escherichia coli O157:H7 in a child care center in Cook County, Illinois, with prolonged shedding and household transmission. Am J Infect Control 2013;41:936–938 [CrossRef][PubMed]
    [Google Scholar]
  28. Gomez DME, Silva A, Deza N, Zotta C, Cotella O et al. Isolation of Shiga-toxin-producing Escherichia coli strains during a gastrointestinal outbreak at a day care center in Mar del Plata City. Rev Argent Microbiol 2005;37:178–183
    [Google Scholar]
  29. Hiruta N, Murase T, Okamura N. An outbreak of diarrhoea due to multiple antimicrobial-resistant Shiga toxin-producing Escherichia coli O26:H11 in a nursery. Epidemiol Infect 2001;127:221–227 [CrossRef][PubMed]
    [Google Scholar]
  30. Dabke G, Le Menach A, Black A, Gamblin J, Palmer M et al. Duration of shedding of Verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England. Epidemiol Infect 2014;142:327–334 [CrossRef][PubMed]
    [Google Scholar]
  31. Sonoda C, Tagami A, Nagatomo D, Yamada S, Fuchiwaki R et al. An enterohemorrhagic Escherichia coli O26 outbreak at a nursery school in Miyazaki, Japan. Jpn J Infect Dis 2008;61:92–93[PubMed]
    [Google Scholar]
  32. MacDonald E, Dalane PK, Aavitsland P, Brandal LT, Wester AL et al. Implications of screening and childcare exclusion policies for children with Shiga-toxin producing Escherichia coli infections: lessons learned from an outbreak in a daycare centre, Norway, 2012. BMC Infect Dis 2014;14:673 [CrossRef][PubMed]
    [Google Scholar]
  33. McMaster C, Roch EA, Willshaw GA, Doherty A, Kinnear W et al. Verocytotoxin-producing Escherichia coli serotype O26:H11 outbreak in an Irish crèche. Eur J Clin Microbiol Infect Dis 2001;20:430–432[PubMed]
    [Google Scholar]
  34. Collins A, Fallon UB, Cosgrove M, Meagher G, Ni Shuileabhan C. A 10-year analysis of VTEC microbiological clearance times, in the under-six population of the Midlands, Ireland. Epidemiol Infect 2017;145:1577–1583 [CrossRef][PubMed]
    [Google Scholar]
  35. Brown JA, Hite DS, Gillim-Ross LA, Maguire HF, Bennett JK et al. Outbreak of shiga toxin-producing Escherichia coli serotype O26: H11 infection at a child care center in Colorado. Pediatr Infect Dis J 2012;31:379–383 [CrossRef][PubMed]
    [Google Scholar]
  36. Tourdjman M, Hostetler T, Reuer J, Ciaffoni C, Cieslak P et al. Duration of shedding and secondary household transmission of Shiga toxin-producing Escherichia coli O26 during an outbreak in a childcare center, Oregon, October-December 2010. J Pediatric Infect Dis Soc 2012;1:329–332 [CrossRef][PubMed]
    [Google Scholar]
  37. Freedman SB, Xie J, Neufeld MS, Hamilton WL, Hartling L et al. Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis. Clin Infect Dis 2016;62:1251–1258 [CrossRef][PubMed]
    [Google Scholar]
  38. Geerdes-Fenge HF, Löbermann M, Nürnberg M, Fritzsche C, Koball S et al. Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. Infection 2013;41:669–673 [CrossRef][PubMed]
    [Google Scholar]
  39. Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N et al. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin Nephrol 1999;52:357–362[PubMed]
    [Google Scholar]
  40. Nitschke M, Sayk F, Härtel C, Roseland RT, Hauswaldt S et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 2012;307:1046–1052 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000738
Loading
/content/journal/jmm/10.1099/jmm.0.000738
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error